Displaying drugs 1751 - 1775 of 1778 in total
(R)-3-hydroxydecanoyl-CoA
Experimental
(R)-methylmalonyl-CoA
Experimental
Nitromethyldethia coenzyme A
Experimental
Malonyl-CoA
A coenzyme A derivative which plays a key role in the fatty acid synthesis in the cytoplasmic and microsomal systems.
Experimental
Etarfolatide
Etarfolatide has been used in trials studying the treatment and diagnostic of Breast Neoplasms, Non Small Cell Lung Cancer, and Adenocarcinoma of the Lung.
Investigational
Myristoyl-Coa
Experimental
Dodecyl-Coa
Experimental
Cibinetide
Cibinetide has been used in trials studying the basic science of Depression.
Investigational
GE-2270A
Experimental
Efonidipine
Efonidipine is a calcium channel blocker of the dihydropyridine class, commercialized by Shionogi & Co. (Japan). Initially, it was marketed in 1995 under the trade name, Landel. The drug has been shown to block T-type in addition to L-type calcium channels [A7844, A32001]. It has also been studied in atherosclerosis...
Experimental
4-hydroxyphenacyl coenzyme A
Experimental
Angiotensin 1-7
TXA127 has been investigated for the treatment of Miscellaneous Peripheral Blood Cell Abnormalities.
Investigational
Interferon Gamma
Interferon gamma is a Type 1 inflammatory cytokine and the only type II interferon. It has antitumor properties, antiviral activities, and important immunoregulatory functions. The interferon is primarily produced by activated T lymphocytes and natural killer cells.
Investigational
S-4-Nitrobutyryl-CoA
Experimental
4-(N,N-Dimethylamino)cinnamoyl-CoA
Experimental
Mipsagargin
Mipsagargin has been used in trials studying the treatment of Prostate Cancer, Prostatic Neoplasms, Advanced Solid Tumors, Glioblastoma Multiforme, and Hepatocellular Carcinoma, among others.
Investigational
Inbakicept
Inbakicept is a dimeric human IL-15 receptor α (IL-15Rα) sushi domain/human IgG1 Fc fusion protein. It is one of the active ingredients in Anktiva, a combination product also containing nogapendekin alfa, where a single inbakicept is complexed with two nogapendekin alfa components. This combination product was approved by the FDA...
Investigational
4-hydroxybenzoyl-CoA
Experimental
(S)-Hmg-Coa
Experimental
Ripasudil
Ripasudil, as hydrochloride hydrate (K-115), is a specifc Rho-associated coiled-coil containing protein kinase (ROCK) inhibitor used for the treatment of glaucoma and ocular hypertension. It was first approved for treatment in Japan in September 2014. This medication is available in the form of a 0.4% eye drop solution under the...
Experimental
Displaying drugs 1751 - 1775 of 1778 in total